305 related articles for article (PubMed ID: 34269536)
1. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
Sohn B; Park K; Ahn SS; Park YW; Choi SH; Kang SG; Kim SH; Chang JH; Lee SK
J Neurooncol; 2023 Sep; 164(2):341-351. PubMed ID: 37689596
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Kang Y; Hong EK; Rhim JH; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SW; Choi SH
Korean J Radiol; 2020 Jun; 21(6):707-716. PubMed ID: 32410409
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
5. A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
Su X; Sun H; Chen N; Roberts N; Yang X; Wang W; Li J; Huang X; Gong Q; Yue Q
Clin Radiol; 2020 Dec; 75(12):963.e7-963.e15. PubMed ID: 32921406
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
[TBL] [Abstract][Full Text] [Related]
7. Radiomics in peritumoral non-enhancing regions: fractional anisotropy and cerebral blood volume improve prediction of local progression and overall survival in patients with glioblastoma.
Kim JY; Yoon MJ; Park JE; Choi EJ; Lee J; Kim HS
Neuroradiology; 2019 Nov; 61(11):1261-1272. PubMed ID: 31289886
[TBL] [Abstract][Full Text] [Related]
8. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
10. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
11. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
[TBL] [Abstract][Full Text] [Related]
12. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
13. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
[TBL] [Abstract][Full Text] [Related]
14. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
15. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
Park JE; Kim HS; Park SY; Nam SJ; Chun SM; Jo Y; Kim JH
Radiology; 2020 Feb; 294(2):388-397. PubMed ID: 31845844
[TBL] [Abstract][Full Text] [Related]
16. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
17. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
[TBL] [Abstract][Full Text] [Related]
18. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
[TBL] [Abstract][Full Text] [Related]
19. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
[TBL] [Abstract][Full Text] [Related]
20. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
